Literature DB >> 10772937

Arginines 97 and 108 in CYP2C9 are important determinants of the catalytic function.

M Ridderström1, C Masimirembwa, S Trump-Kallmeyer, M Ahlefelt, C Otter, T B Andersson.   

Abstract

Human cytochrome P450 2C9 (CYP2C9) is one of the major drug metabolising enzymes which exhibits a broad substrate specificity. The B-C loop is located in the active-site but has been difficult to model, owing to its diverse and flexible structure. To elucidate the function of the B-C loop we used homology modelling based on the Cyp102 structure in combination with functional studies of mutants using diclofenac as a model substrate for CYP2C9. The study shows the importance of the conserved arginine in position 97 and the arginine in position 108 for the catalytic function. The R97A mutant had a 13-fold higher K(m) value while the V(max) was in the same order as the wild type. The R108 mutant had a 100-fold lower activity with diclofenac compared to the wild-type enzyme. The other six mutants (S95A, F100A, L102A, E104A, R105A, and N107A) had kinetic parameters similar to the CYP2C9 wild-type. Our homology model based on the CYP102 structure as template indicates that R97, L102, and R105 are directed into the active site, whereas R108 is not. The change in catalytic function when arginine 97 was replaced with alanine and the orientation of this amino acid in our homology model indicates its importance for substrate interaction. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10772937     DOI: 10.1006/bbrc.2000.2538

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Role of conserved Asp293 of cytochrome P450 2C9 in substrate recognition and catalytic activity.

Authors:  Jack U Flanagan; Lesley A McLaughlin; Mark J I Paine; Michael J Sutcliffe; Gordon C K Roberts; C Roland Wolf
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

2.  CYP isoform specificity toward drug metabolism: analysis using common feature hypothesis.

Authors:  M Ramesh; Prasad V Bharatam
Journal:  J Mol Model       Date:  2011-05-12       Impact factor: 1.810

3.  Structural characterization of human cytochrome P450 2C19: active site differences between P450s 2C8, 2C9, and 2C19.

Authors:  R Leila Reynald; Stefaan Sansen; C David Stout; Eric F Johnson
Journal:  J Biol Chem       Date:  2012-11-01       Impact factor: 5.157

4.  Intramolecular heme ligation of the cytochrome P450 2C9 R108H mutant demonstrates pronounced conformational flexibility of the B-C loop region: implications for substrate binding.

Authors:  Arthur G Roberts; Matthew J Cheesman; Andrew Primak; Michael K Bowman; William M Atkins; Allan E Rettie
Journal:  Biochemistry       Date:  2010-09-21       Impact factor: 3.162

5.  Engineering human cytochrome P450 enzymes into catalytically self-sufficient chimeras using molecular Lego.

Authors:  Vikash Rajnikant Dodhia; Andrea Fantuzzi; Gianfranco Gilardi
Journal:  J Biol Inorg Chem       Date:  2006-07-22       Impact factor: 3.358

6.  Effective virtual screening protocol for CYP2C9 ligands using a screening site constructed from flurbiprofen and S-warfarin pockets.

Authors:  Tímea Polgár; Dóra K Menyhárd; György M Keseru
Journal:  J Comput Aided Mol Des       Date:  2007-10-25       Impact factor: 3.686

7.  Functional analysis of phenylalanine residues in the active site of cytochrome P450 2C9.

Authors:  Carrie M Mosher; Matthew A Hummel; Timothy S Tracy; Allan E Rettie
Journal:  Biochemistry       Date:  2008-10-16       Impact factor: 3.162

8.  Re-engineering of CYP2C9 to probe acid-base substrate selectivity.

Authors:  Guoying Tai; Leslie J Dickmann; Nicholas Matovic; James J DeVoss; Elizabeth M J Gillam; Allan E Rettie
Journal:  Drug Metab Dispos       Date:  2008-07-07       Impact factor: 3.922

9.  Structural Basis of Single-Nucleotide Polymorphisms in Cytochrome P450 2C9.

Authors:  Keiko Maekawa; Motoyasu Adachi; Yumiko Matsuzawa; Qinghai Zhang; Ryota Kuroki; Yoshiro Saito; Manish B Shah
Journal:  Biochemistry       Date:  2017-10-03       Impact factor: 3.162

10.  Quantum mechanics/molecular mechanics modeling of regioselectivity of drug metabolism in cytochrome P450 2C9.

Authors:  Richard Lonsdale; Kerensa T Houghton; Jolanta Żurek; Christine M Bathelt; Nicolas Foloppe; Marcel J de Groot; Jeremy N Harvey; Adrian J Mulholland
Journal:  J Am Chem Soc       Date:  2013-05-16       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.